Form D — Strand Therapeutics Inc.
0001231919-26-000259 · filed 2026-03-17
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $120,099,940
- Total sold
- $108,099,927
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Strand Therapeutics Inc.
- CIK
- 1778475
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 20 Overland Street
Boston, MA 02215 - Phone
- 617-993-9271
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jacob Becraft · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Tasuku Kitada · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Ala Alenazi · DirectorBoston, MA Find on LinkedIn ↗
-
Pegah Ebrahimi · DirectorBoston, MA Find on LinkedIn ↗
-
Jory Bell · DirectorBoston, MA Find on LinkedIn ↗
-
Jeb Keiper · DirectorBoston, MA Find on LinkedIn ↗
-
Samta Kundu · Executive OfficerBoston, MA Find on LinkedIn ↗
View original on SEC EDGAR.